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ABSTRACT
 Production of bioactive compounds is intimately linked to the ecology of the producing organisms. Taking this into ac-
count, the objective of this study was to evaluate the bioactive properties of isolated Actinobacteria from sea sediments 
of a high biodiversity zone; under the hypothesis that the ecological characteristics of this site stimulate the presence 
of unique and bioactive strains that can be screened for new compounds with antibiotic and anticancer properties. The 
elected zone was the Loreto Bay National Park in the Gulf of California Mexico, a protected natural area, with high diver-
sity of flora and fauna. The bioactive properties of strains from this area were different to that reported elsewhere. The 
cytotoxic activity tested by in vitro assays was present in 40% of the tested strains and antibacterial activity in 71% of 
all evaluated strains. This percentage of active strains resulted unusually high when it was compared to similar studies 
from other regions of the world. This supports the hypothesis of the influence of ecological characteristics of the area of 
study on the presence of unique and bioactive Actinobacteria. Thereby, the Actinobacteria community found in Loreto Bay, 
in the Gulf of California, which presented unusual bioactive properties, represents a potential source for obtaining novel 
compounds with antibacterial and anticancer activity.
 Key words: Antibiotic activity, Gulf of California, Loreto Bay, Marine Actinobacteria, Salinispora. 
RESUMEN
 La producción de compuestos bioactivos está íntimamente ligada con la ecología de los organismos que los producen. 
Tomando esto en cuenta, el objetivo de este estudio fue evaluar las propiedades bioactivas de actinobacterias aisladas 
en el sedimento marino de una región con alta biodiversidad; bajo la hipótesis de que las características ecológicas de 
este sitio estimulan la presencia de cepas de actinobacterias únicas y bioactivas que pueden ser útiles en la búsqueda de 
nuevos compuestos con actividad antibiótica y anticancerígena. La zona de estudio elegida fue el Parque Nacional Bahía 
de Loreto en el Golfo de California. México, un área natural protegida, con alta diversidad de flora y fauna. Las propiedades 
bioactivas de las cepas procedentes de esta zona fueron diferentes a la reportada en otros sitios. La actividad citotóxica 
probada mediante ensayos in vitro estuvo presente en 40% de las cepas probadas y la actividad antibacterial en el 71% 
de todas las cepas evaluadas. Este porcentaje de cepas activas resultó inusualmente alto cuando se comparó con estu-
dios realizados en otros sitios del mundo. Esto apoya la hipótesis de la influencia de las características ecológicas de la 
zona de estudio sobre la presencia de actinobacterias únicas y bioactivas. Por lo tanto, la comunidad de actinobacterias 
encontrada en Bahía de Loreto, en el Golfo de California, la cual presentó propiedades bioactivas inusuales, representa un 
recurso potencial para la obtención de nuevos compuestos con actividad antibiótica y anticancerígena.
 Palabras clave: Actinobacterias marinas, actividad antibiótica, Bahía de Loreto, Golfo de California, Salinispora.
Hidrobiológica 2015, 25 (2): 223-229
224 Faviola Cardoso-Martínez et al.
Hidrobiológica
INTRODUCTION
Actinobacteria are the main source of bioactive compounds with me-
dical importance known to date. Very important strains of this class, 
such as Streptomyces, have been isolated from terrestrial sources in 
the past. However, as of three decades ago, several bioactive Actino-
bacteria have been isolated from the marine environment (Kim et al., 
2006; Gontang et al., 2007; Pommier et al., 2007). 
The Actinobacteria taxons isolated from the sea are the producers 
of several bioactive metabolites never seen in terrestrial taxons (Fenical 
& Jensen, 2006; Bull & Stach, 2007). Therefore, marine Actinobacteria 
have been recognized, up to now, as the most economically as well as 
biotechnologically valuable prokaryotes (Dharmaraj, 2010; Manivasa-
gan et al., 2013).
One of the most prolific marine Actinobacteria belongs to the Sali-
nispora genus, which is the producer of several new compounds with 
high cytotoxic activity against  HCT-116 cell line such as, arenicolide, 
salinosporamide A, staurosporine and arenimycin (Gerner & Meyskens, 
2004; Williams et al., 2007a, 2007b; Fenical et al., 2009; Asolkar et al., 
2010). In fact, the salinosporamide A, is now in early clinical trials as 
potent anticancer agent (Fenical et al., 2009).
A well-known and widely accepted explanation of the high bio-
activity and the great difference among marine and terrestrial Actino-
bacteria is the presence of different environmental conditions between 
them. It is surmised that marine Actinobacteria, which had to adapt 
during evolution to more extreme environmental conditions, reflect this 
evolutionary history in their genetic and metabolic diversity and in the 
production of different kinds of bioactive compounds. Furthermore, ma-
rine Actinobacteria that are geographically isolated from the rest could 
also present different bioactivity due to the high rates of mutation and 
horizontal gene transference.
The Gulf of California, Mexico (also known as Sea of Cortez) is a 
semiclosed, highly productive body of water characterized as having 
abundant biological resources and a high level of endemism. In  the 
Gulf of California sediment  several Actinobacteria related to the gen-
era Actinomadura, Dietzia, Gordonia, Micromonospora, Nocardiopsis, 
Nonomuraea, Rhodococcus, Saccharomonospora, Salinispora, Strepto-
myces, “Solwaraspora” and Verrucosispora (Maldonado et al., 2009; 
Becerril-Espinosa et al., 2013) have been isolated. In addition, several 
species considered marines autochthones such as Micromonospora 
krabiensis (strain AMS264, HQ877446, 99.06% of similarity), Saccha-
romonospora marina (strain AML899, HQ877432, 99.54% of similar-
ity), Streptomyces fenhuangensis (strain AML250, 98.71% similarity), 
Verrucosispora maris (strain AMS604, HQ877435, 99.42% of similarity) 
and Verrucosispora sediminis (strain  AMS180, 98.76% of similarity) 
have been found; moreover, in the Gulf of California, new taxons have 
been discovered, including two restricted marine taxons related to the 
genera Streptomyces and Salinispora (Becerril-Espinosa et al., 2013). 
The Gulf of California still possesses ecosystems not yet impacted 
by anthropogenic activity such as Loreto Bay, which is considered a 
natural protected area and categorized as National Park (Diario Oficial, 
2002). It is feasible to find marine biota in Loreto Bay that is not found in 
any other place in the world. As such, we test the hypothesis that Acti-
nobacteria strains from Loreto Bay National Park possess different bio-
activity properties to the ones isolated from other regions of the world.
MATERIALS AND METHODS
In this research, marine Actinobacteria strains previously isolated and 
identified according to 16S rRNA in Becerril-Espinosa et al. (2013) were 
used.  The strains  were isolated from 4 different locations in Lore-
to Bay: site S1 is named mainland beach (25° 50.2’N, 111° 19.4’W 
































Figure 1. Map of the Gulf of California in the left. Enlargement of Loreto Bay area in the right. Sampling sites as follow: red circles indicates sites of the area 1(S1), 
green circles indicate sites of the area 2 (S2), purple circles indicates sites of the area 3 (S3) and brown circles indicate sites of the area 4 (S4).
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named island beach (25° 48’N, 111° 15.35’W); site S3 is named Dan-
zante Island Northwest zone (25° 57.0’N, 111° 18.37’W to 25° 48’N 
111° 15.42’W) and site S4 was named Danzante Island East zone (25° 
48.91’N, 111° 14.36’W to 25° 47.95’N, 111° 14.32’W). Sites S1 and 
S2 are located near the shoreline at very shallow depths (0 -15 m) 
while sites S3 and S4 were located in deeper sites of the national park 
(200-300 m) (Fig. 1). The isolation was performed using the plate stam-
ping technique (Mincer et al., 2002). The 16S rRNA sequences were 
taken from GenBank (http://www.ncb.nlm.nih.gov/genbank/index.html) 
under the accession numbers HQ873926-HQ873952 and HQ877423-
HQ877448. 
A total of 216 Actinobateria were selected for this study. Accord-
ing to Becerril-Espinosa et al. (2013) these strains were grouped as 
follows: Group I (29 strains) bacteria with mycelium substrate morphol-
ogy and with no requirement of seawater for growth (Micromonospora), 
Group II (127 strains) strains with mycelium substrate morphology and 
with a requirement of seawater for growth (Salinispora) and Group III 
(60 strains) strains with aerial mycelium and no requirement of seawa-
ter for growth (Streptomyces). 
Phylogenetic analysis for bioactive Actinobacteria. 16S rRNA gene 
sequences of bioactive strains (1300 bp) were assembled and analy-
zed using BLAST (Basic Local Alignment Search Tools) (Altschul et al., 
1990) and aligned using the ClustalX program (Staley & Konopka, 1985) 
and then imported into the Bioedit program (Hall & Brown, 2001) with 
manual alignment. The phylogenetic tree was constructed with the 
neighbor-joining algorithm with 10,000 replications using the MEGA4 
program (Tamura et al., 2007) and a 1300 bp segment. 
Operational taxonomic units (OTUs). 16S rRNA gene sequences 
(1300 bp) of bioactive strains were aligned and grouped into OTUs ba-
sed on 98% of the identity sequences using the Cluster program (http://
www.bugaco.com/mioritic/clusterer_jlp.php).
Preparation of organic extracts. Before the bioactivity test, Actino-
bacteria strains preserved in glycerol were grown in A1 media (18 g 
agar, 10 g starch, 2 g peptone, 4 g yeast extract, 1l natural sea water) 
(Mincer et al. 2002; Gontang et al. 2007), then a well-defined young 
colony was transferred to 10 ml of liquid A1 media and growth was 
allowed for 3 to 5 days at 25 °C with continuous stirring at 215 rpm to 
induce higher biomass. After 3-5 days the 10 ml culture was transfe-
rred into 100 ml of A1 media at same temperature and agitation for 8 
days. After this period, Amberlite XAD7 was added at a concentration 
of 20 g/l of media allowing agitation for 2 h at 100 rpm.  Amberlite was 
then filtered and washed with 100 ml of acetone for 2 h at 100 rpm. 
Finally, the extract was filtered, concentrated and kept at 15 °C, ready 
to use in the bioactivity tests.
Antibiotic activity. For antibiotic activity, the sensitivity or resistance of 
the Gram negative pathogens Pseudomonas aeruginosa (ATCC27853) 
and Proteus vulgaris (ATCC13315) and the Gram positive pathogen me-
thicillin resistant Staphylococcus aureus (MRSA), were tested using pa-
per discs impregnated with the organic extract. Each pathogen was cul-
tured at a final concentration of 105 colony formed units (UFC)/ml, and 
an aliquot of 1 ml was massively inoculated into nutritive agar. All the 
assays were performed by triplicate. At the end of the inoculation, the 
paper discs impregnated with each organic extract at a concentration 
of 10µg/ml were positioned into the Petri dish. Bacterial growth was 
allowed for 24-48 h at 37 °C before the reading of the inhibition zone. 
The Gram negative pathogens were selected due to their resistance 
to rifampicin, which is actively secreted by most of the Actinobacteria 
strains of group II (Salinispora; Jensen et al., 2007). The Gram positive 
bacteria were included to see a wide range of activity in the analyzed 
strains, as well as the high activity in Salinispora arenicola (Asolkar et 
al., 2010) and Streptomyces strains (Torres-Beltrán et al., 2012). There-
fore, the positive antimicrobial activity evaluated here is due to different 
and potentially new antibiotic compounds. 
Cytotoxic activity. Each organic extract was tested against human 
colon carcinoma cells HCT-116, human lung cancer cells H460 and 
human cervical cancer cells HeLa. Bioassays of   HCT-116 cells were 
performed at a concentration of 10 mg/ml of the dry organic extract 
in dimethyl sulfoxide (DMSO) and the medium inhibitory concentration 
IC50 (µg/ml) was calculated from the activity assay according to the me-
thod described in Becerril-Espinosa et al. (2012); bioassays of H460 
lung cancer cells  and HeLa breast cancer cells  were performed at a 
concentration of 20 mg/ml of dry organic extract in dimethyl sulfoxide 
(DMSO), from which the survival rate of less than 50% was obtained 
under conditions described by Torres-Beltrán et al. (2012); all the as-
says were realized by triplicate.
RESULTS
Antibiotic activity.  71.0% (154 strains) of Actinobacteria organic ex-
tracts (217 extracts) showed antibiotic activity against at least one of 
the pathogens tested. From the bioactive strains, 43.0% (66) showed 
activity against Pseudomona aeruginosa, 69.0% (47 strains) against 
Proteus vulgaris and 30.5% (47 strains) against MRSA. In addition, from 
the bioactive strains, only 19 showed an inhibition zone smaller than 10 
mm in diameter, while the rest (135) of the strains showed an inhibition 
zone between 10 and 30 mm in diameter, which is considered a strong 
inhibition.
Of the 29 strains from group I, 38.0% (11 strains) showed activ-
ity against P. aeruginosa, 45.0% (13 strains) showed activity against P. 
vulgaris and 17.0% (5 strains) were active against MRSA. Of the 127 
strains from group II, 27.0% (34 strains) showed activity against P. ae-
ruginosa, 46.4% (59 strains) showed activity against P. vulgaris and 
13.0% (17 strains) showed activity against MRSA. Of the 60 strains 
from Group III, 35.0% (21 strains) showed activity against P. aeruginosa, 
58.0% (35 strains) showed activity against P. vulgaris and 42.0% (25 
strains) were active against MRSA (Fig. 2). 
The selected strains were grouped into 16 OTUs based on 98% 
similitude to the 16S rRNA sequence, of which two OTUs showed activ-
ity only against P. aeuroginosa, two OTUs where bioactive only against 
P. vulgaris and one OTU showed activity against MRSA, seven OTUs 
showed activity against both pathogens  and four OTUs showed activity 
against three pathogens (Table 1).
Cytotoxic activity. From the 217 organic extracts prepared, only 89 
strains belonging of the Micromonosporaceae family, specifically the 
Micromonospora and Salinispora genus,  were the most important  ac-
cording to these and previous investigations for this geographic zone 
(Maldonado et al., 2009; Becerril-Espinosa et al., 2013). Only 24 strains 
of Group I (Micromonospora) and 65 strains of group II (Salinispora) 
where assayed for cytotoxic activity. From the 89 Actinobacteria tested, 
36 strains (40.0 %) showed cytotoxic activity, from which 20 strains 
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(55.5%) were active against  HCT-116 cell line, 11 strains (30.5%) were 
active against  HeLa cell line, and 9 strains (25%) were active against 
H460 cell line (Fig.2).  From all the bioactive strains, only four strains 
presented activity against two cell lines and one strain presented acti-
vity against the three cell lines. 
Of the 24 strains related to the  Micromonospora ssp. genera 
(group I) only 6 extracts (25%) had cytotoxic activity; for strains related 
to the  Salinispora genus (group II) cytotoxic activity was present in 30 
(46.15%) of 65 assayed strains (Fig. 2). 
Molecular classification. A few bacteria from Loreto Bay were related, 
according to the 16S rRNA, to bioactive strains isolated in other regions 
of the world. For example, the strain AMS515 (HQ873952) is related 
to the S. arenicola (CP000850, 99.27% similarity) producer of several 
bioactive compounds (Fenical & Jensen, 2006), and the strains rela-
ted to the genus Streptomyces such as the strain AML852 (HQ873944) 
of group III was related to the type of Streptomyces hygroscopicus 
subsp. hygroscopicus (AB184428, 97.36% similarity), the marine stra-
ins of Streptomyces sp. (EU214940, 100% similarity, and  TFS59-23 
(HM001271, 97.65% similarity),  which has  antibacterial and antifungal 
activity (Engelhardt et al., 2010) (Fig. 3).
DISCUSSION
Antibiotic activity. The three Actinobacteria groups isolated from Lo-
reto Bay and assayed for antibiotic activity: Micromonospora (GI), Sali-
nispora (GII) and Streptomyces (GIII) where highly bioactive against the 
pathogens tested. The antibiotic activity showed by the strains of  group 
I and  II was very similar, due probably to the fact that they  belong 
to the same family (Micromonosporaceae). This behavior was different 
for  the group III strain. The highest proportion of Actinobacteria with 
antibiotic activity belonged to this group (Streptomyces). Moreover se-
veral of these strains where highly active against the gram positive 
pathogen MRSA. This finding is very important nowadays, because of 
the increasing number of resistant pathogen bacteria to many of the 
known antibiotics. In this regard, the evaluation of the antibiotic activity 
investigated in this study contributes to the effort to isolate and eluci-
date novel antibiotic compounds capable to fight resistant pathogens.
Citotoxic Activity. Nowadays, the Salinispora genus is considered 
the most prolific in terms of production of new compounds (Ziemert et 
al. 2014). This information was important in the selection of strains for 
this study  due to the high cost of the cytotoxic tests. Therefore and due 
to the fact that they belong to the same family (Micromonosporaceae) 
only the extracts belonging to  the Salinispora and  Micromonospora 
genus (group II and III), were used to evaluate cytotoxicity.  As expected, 
several Salinispora strains and a few of Micromonospora were active 
against different cell lines.  It is an expected result due to the unique 
diversity of strains related to Salinispora genus previously found in the 
Gulf of California. In this region new phylotypes of S. pacifica “k” and 
S. arenicola “A” and “B” has been discovered. No formal description 
or metabolic characterization has been presented for these bacteria. 
However, it was reported that new phylotypes present ketosynthase do-
mains encoding the synthesis of new compounds (Edlund et al., 2011; 
Becerril-Espinosa et al., 2013). Therefore a high possibility of finding 
new compounds able to fight cancer in any of the 30 different strains of 
Salinispora that resulted cytotoxic in this study exists.
A particular bioactivity behaviour found in actinobacteria 
strains of Loreto Bay. The capacity of Actinobacteria to produce sec-
ondary metabolites is widely accepted. However is quite interesting to 
Table 1. Antibiotic activity of Actinobacteria against Proteus vulgaris ATCC33152, Pseudomona aeruginosa ATCC27853 and Methicillin Resistant 
Staphylococcus aureus (MRSA). 
Family Genera Group # OTU
    Bioactivity
P. vulgaris P. aeruginosa MRSA
Micromonosporaceae Micromonospora GI 1 + - -
Micromonospora GI 2 - + -
Micromonosporaceae Salinispora GII 3 + - +
Streptomycetaceae Streptomyces GII 4 - - +
Streptomyces GIII 5 - + -
Streptomyces GIII 8 - + +
Streptomyces GIII 7 + + +
Streptomyces GIII 8 + + -
Streptomyces GIII 9 + + -
Streptomyces GIII 10 + - +
Streptomyces GIII 11 + + +
Streptomyces GIII 12 + - +
Streptomyces GIII 13 + + +
Streptomyces GIII 14 + -  -
Streptomyces GIII 15 + + -
Streptomyces GIII 16 + + +
Symbols utilized: + (activity), - (no activity. OTUs with 98% of identity
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Figures 2a-b. a) Percentage of active organic extracts from Actinobacteria of group I (Micromonospora), II (Salinispora) and III (Streptomyces) against the pathogen 
bacteria: Proteus vulgaris, Pseudomona aeruginosa and Methicillin Resistant Staphylococus aerus (MRSA). b) Percentage of active organic extracts from Actinobacte-
ria of group I, II and III against human colon carcinoma cells HCT-116, human lung cancer cells H460 and human cervical cancer cells HeLa. 
note that the recuperation percentage of bacteria with antibiotic activity 
found in this work is quite different to other regions. For example, Ellaiah 
et al. (2004) reported 18 to 30% antibiotic activity of Actinobacteria iso-
lated in a bay of the Bengal Ocean near the Kakinada coast of Andhra 
Pradesh, India, and Valli et al. (2012) reported 9.5% and 23% antibiotic 
activity against P. aeruginosa and P. vulgaris respectively; which are at 
least two times less than the 71% of recuperation percentage of Actino-
bacteria with antibiotic activity found in this work. It is probable that the 
Biosphere reserve of Bahía de Loreto, which represents a non-impacted 























































tions as to induce this variability on bioactivity. It is known that isolated 
strains from different places and at different conditions have evolved in 
their own way.  Factors that influence on the presence or dominance of 
bioactive over no-active Actinobacteria has not been investigated for-
mally and could be very interesting in ecological terms and beneficial 
for planning future sampling expeditions for biotechnological purposes. 
From the actual study, it is possible to conclude that the Actinobacteria 
community found in Loreto Bay, in the Gulf of California, which pos-
sesses unusual bioactive properties represents a potential source of 
novel compounds with antibacterial bioactivity. 
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